Correction to: Neuropsychopharmacology https://doi.org/10.1038/s41386-021-01237-6, published online 02 December 2021
In this article the wrong table appeared in abstract “P315. No Meaningful Opioid Abuse Liability of REL-1017.
(Esmethadone; D-Methadone), a Rapid-Acting Antidepressant in Clinical Development: A Human Abuse Potential Study”; the table should have appeared as shown below. The original article has been corrected.
Mean | PL: 51.7 | 25R: 53.0 | 75R: 58.2 | 150R: 64.9 | OX: 85.0 |
|---|---|---|---|---|---|
Median | PL: 50.0 | 25R: 50.0 | 75R: 50.0 | 150R: 58.0 | OX: 89.0 |
P-value vs. OX | <0.001 | <0.001 | <0.001 | <0.001 | |
P-value vs. PL | <0.001 | <0.001 | <0.10 |
Rights and permissions
About this article
Cite this article
Correction: ACNP 60th Annual Meeting: Poster Abstracts P276 – P550. Neuropsychopharmacol. 47, 1871 (2022). https://doi.org/10.1038/s41386-022-01318-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41386-022-01318-0
